Search for Clinical Trial Results

Sponsored By

Neurofibroma - 175 Studies Found

Status Study
Active, not recruiting Study Name: Pilot Study of Gleevec/Imatinib Mesylate (STI-571, NSC 716051) in Neurofibromatosis (NF1) Patient With Plexiform Neurofibromas
Condition:
  • Neurofibromatosis
  • Neurofibromas Date: 2010-06-08
    Interventions: Drug: Gleevec Gleevec will be dosed orally with a starting dose of 100 mg twice daily for patients with
Terminated Study Name: Phase I Clinical Study of the Safety of Photodynamic Therapy (PDT) Using LS11 in Children With Plexiform Neurofibromas
Condition: Neurofibroma
Date: 2008-07-14
Interventions: Drug: LS11 LS11 will be given as a one-time IV infusion over 3-5 minutes.
Terminated Study Name: First Clinical Study of Erbium - Yttrium Aluminium Garnet (YAG) Laser Vaporization of Cutaneous Neurofibromas
Condition: Cutaneous Neurofibromas
Date: 2009-06-15
Interventions: Procedure: Erbium-YAG laser vaporization spot size 2-5 mm diameter, applying about 1,2 -2 J at a frequen
Completed Study Name: Natural History and Biology of Skin Neurofibromas in Neurofibromatosis Type 1
Condition:
  • Neurofibromas
  • Neurofibromatosis Ty
    Date: 2006-04-11
Active, not recruiting Study Name: Study of PEG-Intron for Plexiform Neurofibromas
Condition: Plexiform Neurofibroma
Date: 2006-11-02
Interventions: Drug: PEG-Intron
Completed Study Name: Ranibizumab for Neurofibromas Associated With Neurofibromatosis 1
Condition:
  • Neurofibromatosis Type 1
  • Cutaneous Neurof
    Date: 2008-03-27
    Interventions: Drug: Ranibizumab Given as an injection into three cutaneous neurofibromas on day 1 of the study treatme
Recruiting Study Name: Study of Imatinib Mesylate in Neurofibromatosis Type I Patients Aged 2 to 21 With Plexiform Neurofibromas
Condition: Plexiform Neurofibromas
Date: 2014-06-25
Interventions: Drug: Imatinib Mesylate oral administration Other Na
Terminated Study Name: Efficacy and Safety of RAD001 in Treating Plexiform Neurofibromas (PN) Associated With Neurofibromatosis (NF1)
Condition: Plexiform Neurofibroma Associated With Neurofibromatosis Type 1
Date: 2011-05-27
Interventions: Drug: Everolimus (RAD001) oral daily dosing of tablet starting with 2.5 mg
Completed Study Name: R115777 to Treat Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Condition:
  • Neurofibroma, Plexiform
  • Neurofibromatosis
    Date: 2006-06-19
    Interventions:
    • Drug: tipifarnib Given orally,
Active, not recruiting Study Name: Use of Topical Liquid Diclofenac Following Laser Microporation of Cutaneous Neurofibromas in Patients With NF1
Condition:
  • Neurofibromatosis 1
  • Cutaneous Neurofibrom
    Date: 2017-03-08
    Interventions:
    • Drug: Diclofenac Sodium Follow
Next >>>